Biotech Nabs $200M Via Private Placement, Starts CEO Search
Public gene therapy company enGene Holdings Inc. announced Wednesday that it will sell 20 million of its common shares, raising an anticipated private placement of around $200 million, to fund the...To view the full article, register now.
Already a subscriber? Click here to view full article